Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
99 studies found for:    Sjögren's Syndrome
Show Display Options
Rank Status Study
1 Recruiting Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CFZ533 active;   Drug: CFZ533 placebo
2 Active, not recruiting Low Dose Cyclosporin A in Primary Sjögren Syndrome
Condition: Sjögren´s Syndrome
Intervention: Drug: Cyclosporine A
3 Completed A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
Conditions: Dry Mouth Associated With Sjogren's Syndrome;   Xerostomia
Interventions: Drug: Placebo;   Drug: 552-02
4 Recruiting Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
Conditions: Primary Sjogren's Syndrome;   Secondary Sjogren's Syndrome;   Inflammatory Arthritis;   Rheumatoid Arthritis
Intervention: Drug: Abatacept
5 Unknown  Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)
Conditions: Sjogren's Syndrome;   Mesenchymal Stem Cells
Intervention: Biological: Allogeneic Mesenchymal Stem Cells (AlloMSC)
6 Recruiting Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: SS-1;   Drug: Placebo
7 Recruiting PD of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736;   Drug: Placebo
8 Completed Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Intervention: Drug: Mycophenolate sodium
9 Completed Neurotrophins Implications in Primary Sjögren Syndrome
Condition: Primary Sjögren Syndrome
Intervention: Biological: blood sample
10 Completed Etanercept Therapy for Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Etanercept
11 Recruiting Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome
Conditions: KERATOCONJUNCTIVITIS SICCA;   XEROSTOMIA;   SICCA SYNDROME;   PRIMARY SJOGREN SYNDROME
Interventions: Device: Laser 3R 790nm infrared Ga AIAs;   Device: Laser 3R 790 nm infrared  GaAIAs
12 Completed Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome
Conditions: Autoimmune Diseases;   Sjogren's Syndrome;   Dry Eye
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
13 Completed DHEA Treatment for Sjogren's Syndrome
Conditions: Lacrimal Apparatus Disease;   Salivary Gland Disease;   Sjogren's Syndrome;   Xerostomia
Intervention: Drug: Dehydroepiandrosterone
14 Completed Pilot Study of Thalidomide to Treat Sjogren's Syndrome
Conditions: Sjogren's Syndrome;   Xerostomia
Intervention: Drug: Thalidomide
15 Completed Raptiva to Treat Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Raptiva
16 Active, not recruiting Baminercept in Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Biological: Baminercept;   Other: Placebo
17 Unknown  Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue
Condition: Sjogren's Syndrome
Intervention: Drug: dehydroepiandrosterone
18 Recruiting Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Procedure: Sialoendoscopy;   Drug: saline;   Drug: hydrocortisone
19 Completed Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Intervention: Drug: Belimumab
20 Completed Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
Conditions: Lupus Erythematosus, Systemic;   Sjogren's Syndrome
Intervention: Drug: Dehydroepiandrosterone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years